176 related articles for article (PubMed ID: 25085898)
1. Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.
Vornicova O; Hershkovitz D; Yablonski-Peretz T; Ben-Itzhak O; Keidar Z; Bar-Sela G
Oncologist; 2014 Sep; 19(9):1006-7. PubMed ID: 25085898
[TBL] [Abstract][Full Text] [Related]
2. Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
Maeda T; Kitamura S; Nishihara H; Yanagi T
Oncogene; 2020 Sep; 39(36):5867-5875. PubMed ID: 32724160
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of ERBB2 S310F mutation in extramammary Paget's disease.
Kusaba Y; Kajihara I; Myangat TM; Tanaka K; Kanemaru H; Sawamura S; Makino K; Aoi J; Masuguchi S; Fukushima S
J Dermatol; 2022 Sep; 49(9):e305-e306. PubMed ID: 35582767
[No Abstract] [Full Text] [Related]
4. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2
Nordmann TM; Messerli-Odermatt O; Meier L; Micaletto S; Coppetti T; Nägeli M; Kamarachev J; Kudura K; Freiberger SN; Rordorf T; Mangana J; Braun R; Dummer R
Oncotarget; 2019 Nov; 10(62):6647-6650. PubMed ID: 31803359
[TBL] [Abstract][Full Text] [Related]
5. Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
Watanabe S; Takeda M; Takahama T; Iwasa T; Tsurutani J; Tanizaki J; Shimizu T; Sakai K; Wada Y; Isogai N; Nishio K; Nakagawa K
Invest New Drugs; 2016 Jun; 34(3):394-6. PubMed ID: 26856856
[TBL] [Abstract][Full Text] [Related]
6. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review.
Sekiguchi N; Kubota S; Noguchi T; Fukushima T; Kobayashi T; Kanda S; Koizumi T; Miyake T; Shirai T; Okuyama R
J Dermatol; 2020 Nov; 47(11):1276-1279. PubMed ID: 32706146
[TBL] [Abstract][Full Text] [Related]
7. Whole genome sequencing of HER2-positive metastatic extramammary Paget's disease: a case report.
Lim BY; Guo Z; Lim JQ; Ko TK; Lee ECY; Kannan B; Lee JY; Lim AH; Li Z; Ng CC; Busmanis I; Chan JY
Orphanet J Rare Dis; 2024 Jun; 19(1):223. PubMed ID: 38831459
[TBL] [Abstract][Full Text] [Related]
8. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.
Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Takahashi A; Tsutsumida A; Fujisawa Y; Fujimoto M; Yamazaki N
Clin Exp Metastasis; 2016 Oct; 33(7):687-97. PubMed ID: 27289366
[TBL] [Abstract][Full Text] [Related]
9. p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease.
Reich O; Liegl B; Tamussino K; Regauer S
Mod Pathol; 2005 Mar; 18(3):354-7. PubMed ID: 15272283
[TBL] [Abstract][Full Text] [Related]
10. Sequential use with imiquimod and surgery in extramammary Paget's disease.
Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
12. Extramammary Paget's disease of the external ear canal in association with ceruminous gland carcinoma. A case report.
Fligiel Z; Kaneko M
Cancer; 1975 Sep; 36(3):1072-6. PubMed ID: 171051
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characteristics of extramammary Paget's disease of the scrotum associated with sweat gland adenocarcinoma-a clinical retrospective study.
Yan D; Dai H; Jin M; Zhao Y
J Chin Med Assoc; 2011 Apr; 74(4):179-82. PubMed ID: 21463849
[TBL] [Abstract][Full Text] [Related]
14. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease.
Takata M; Fujimoto A; Aoki H; Hatta N; Ooi A; Takehara K
J Invest Dermatol; 1999 Aug; 113(2):258-62. PubMed ID: 10469313
[TBL] [Abstract][Full Text] [Related]
15. [Expression status of HER2 in mammary and extramammary Paget's disease].
Meng H; Zheng XY; Zhang L; Li WC
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
[No Abstract] [Full Text] [Related]
16. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
Kariya K; Tsuji T; Schwartz RA
Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
Hirai I; Tanese K; Nakamura Y; Otsuka A; Fujisawa Y; Yamamoto Y; Hata H; Fujimura T; Matsushita S; Yoshino K; Kameyama K; Amagai M; Funakoshi T
Med Oncol; 2018 May; 35(6):92. PubMed ID: 29744813
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision.
Fanning J; Lambert HC; Hale TM; Morris PC; Schuerch C
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):24-7. PubMed ID: 9914572
[TBL] [Abstract][Full Text] [Related]
19. High Risk of Proximal and Local Neoplasms in 2206 Patients With Anogenital Extramammary Paget's Disease.
Lee GC; Kunitake H; Stafford C; Bordeianou LG; Francone TD; Ricciardi R
Dis Colon Rectum; 2019 Nov; 62(11):1283-1293. PubMed ID: 31567917
[TBL] [Abstract][Full Text] [Related]
20. Familial occurrence of extramammary Paget's disease.
Kuehn PG; Tennant R; Brenneman AR
Cancer; 1973 Jan; 31(1):145-8. PubMed ID: 4345608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
